Government Affairs
Refine search
Pharmaceutical
Russia is considering a significant increase public procurements of drugs for the treatment of obesity within the next several years, reports The Pharma Letter’s local correspondent. 17 July 2026
Pharmaceutical
Latin American countries need to treat health spending as an investment rather than a cost if they are to expand coverage, strengthen health systems and support broader economic development, according to the Latin American Federation of the Pharmaceutical Industry, FIFARMA. 16 July 2026
Pharmaceutical
A Q&A with Iris Zemzoum, President of Europe Region at Novartis, who believes Europe can no longer separate industrial policy, healthcare policy and patient outcomes into different conversations. 16 July 2026
Biosimilars
US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for Accessible Medicines (AAM) and its Biosimilars Council. 16 July 2026
Pharmaceutical
Every euro invested in innovative medicines generated an estimated 5.67 euros ($6.48) in social and economic value across Europe and six euros in Greece, according to industry-backed analysis highlighted by the Hellenic Association of Pharmaceutical Companies 13 July 2026
Pharmaceutical
Denmark’s pharmaceutical industry has called for major changes to the country’s confidential pricing pilot after only one pharmacy medicine secured an agreement during its first year, despite companies submitting 13 applications. 13 July 2026
Pharmaceutical
A current accusation against the German pharmaceutical industry is that is being given preferential treatment under the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG). 13 July 2026
Pharmaceutical
The Russian government plans to postpone the introduction of "second-extra" rule for vital drugs during public procurements until December, reports The Pharma Letter’s local correspondent. 10 July 2026
Pharmaceutical
India is aiming to double the size of its pharmaceutical industry to $120 billion over the next five years, with the government betting on exports, innovation and global partnerships to sustain the sector's next phase of growth. 7 July 2026
Biotechnology
The 2026 BIO International Convention brought together biotech leaders, policymakers, patients, and innovators to discuss the industry's biggest opportunities and challenges. 6 July 2026
Pharmaceutical
Contract manufacturing facilities located in the USA and Europe provide biopharma companies with strategic options to diversify supply chains, access specialized technologies, and speed time-to-market for new drugs. 6 July 2026
Pharmaceutical
Europe’s research-based pharma industry has urged policymakers to improve coordination across the European Union (EU) to tackle persistent inequalities in access to precision oncology, warning that many patients are still unable to benefit from advances in targeted cancer therapies and biomarker testing. 6 July 2026
Pharmaceutical
Russian pharmaceutical companies and global drugmakers operating in the local market have called on the national government to speed the process of entering new drugs in public procurements after their registration, reports The Pharma Letter’s local correspondent. 3 July 2026
Pharmaceutical
Eastern Europe has long been part of global clinical development, although it is more often covered when disruption affects trial delivery. Russia’s invasion of Ukraine in February 2022 made that pattern more visible. Sponsors, contract research organizations and regulators had to reassess trial continuity, patient retention, site access, medicine supply, sample movement and missing data. 3 July 2026
Biotechnology
The European Federation of Pharmaceutical Industries and Associations (EFPIA) and Vaccines Europe have issued a joint statement. 29 June 2026
Pharmaceutical
A new Milbank Quarterly paper ends the debate: The 340B was never intended to be a hospital markup program that drives up costs for patients, employers and taxpayers, according to US trade group Pharmaceutical Research Manufacturers of America (PhRMA) 24 June 2026
Biotechnology
The US Department of Health and Human Services has launched a department-wide clinical trials reform initiative aimed at accelerating drug development, reducing unnecessary regulatory burden and reinforcing the USA’s position in global biomedical research. 23 June 2026
Pharmaceutical
Greece’s pharmaceutical industry has warned that patient access to innovative medicines could be put at risk after the hospital medicines clawback reached a record 80.7% in the first half of 2025. 22 June 2026
Pharmaceutical
The US Trade Representative (USTR) has launched a Section 301 investigation into Germany’s pharmaceutical pricing policies, escalating a dispute over how the costs of innovative medicines are shared between the USA and other wealthy markets. 22 June 2026
Biotechnology
Chinese life sciences services group WuXi AppTec has sued the US government over its inclusion on a Pentagon list of companies alleged to have links to China’s military, escalating a dispute with potentially wide implications for pharma outsourcing. 22 June 2026
Pharmaceutical
Global pharma companies supplying their drugs for the list of vital medicines in Russia may face with serious difficulties in the local market in the short term due to the ever tightening-requirements from the Russian state, The Pharma Letter’s local correspondent reports. 4 September 2025
Biotechnology
Pfizer, Moderna and Novavax all issued statements Wednesday in response to comments made by US President Donald Trump. 4 September 2025
Pharmaceutical
The US Department of Health and Human Services (HHS) yesterday announced prescription drug reforms are set to take effect October 1, designed to give patients and physicians real-time access to prescription drug costs, insurance coverage details and prior authorization requirements. 3 September 2025
Biotechnology
In a significant move toward self-reliance, the Indian government is doubling down on its commitment to a homegrown biotechnology sector, reports The Pharma Letter’s India correspondent. 3 September 2025
Pharmaceutical
For decades, advisory committees have been a cornerstone of US drug regulation. These panels of outside experts were designed to provide credibility, transparency, and independence in decisions that shape medicine. But recent moves, political shifts, and controversial approvals raise a blunt question: how much influence do they really have left? 3 September 2025
Pharmaceutical
The world’s 20 largest biopharmaceutical companies saw their combined market capitalization fall 5.7% in the second quarter of 2025, slipping from $3.9 trillion at the end of March to $3.7 trillion by June, according to new figures from GlobalData. 1 September 2025
Pharmaceutical
A recent institutional meeting took place in Cairo between Egypt's Deputy Prime Minister and Minister of Health and Population, Khaled Abdel Ghaffar, and the president of Italian trade group Farmindustria, Marcello Cattani. 1 September 2025
Pharmaceutical
Australia’s Therapeutic Goods Administration (TGA) has issued three infringement notices totalling A$59,400 ($38,823), to Victoria-based companies Elixir Compounding Pharmacy Pty Ltd and Elixir Centre for Wellness Pty Ltd. 1 September 2025
Pharmaceutical
The range of drugs available in the Russian market may significantly decrease in the short term due to protectionist measures imposed by the government in regard of domestic drugs, which are purchased at state tenders. 29 August 2025
Pharmaceutical
The division and mixed messaging that has characterized the generalship of US healthcare in recent months has been exposed again in an unseemly saga involving Susan Monarez, director of the Centers for Disease Control and Prevention (CDC). 28 August 2025
Pharmaceutical
The pharmaceutical industry and the UK government have failed to reach agreement on requested changes to a medicines payment scheme. 22 August 2025
Pharmaceutical
US healthcare giant Johnson & Johnson has announced that it will increase its presence in North Carolina with a 160,000+ square foot dedicated manufacturing facility at Fujifilm’s new biopharma manufacturing site in Holly Springs. 22 August 2025
Pharmaceutical
The USA and European Union on Thursday released new details of their trade framework, addressing long-standing disputes and expectations around pharmaceutical and semiconductor tariffs. 22 August 2025
Pharmaceutical
The US Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid Services (CMS) are establishing the Healthcare Advisory Committee - a group of experts charged with delivering strategic recommendations directly to HHS Secretary Robert F Kennedy Jr and CMS Administrator Dr Mehmet Oz to improve how care is financed and delivered across Medicare, Medicaid and the Children's Health Insurance Program (CHIP), and the Health Insurance Marketplace. 22 August 2025
Biotechnology
For what is reportedly the first time in decades, the American Academy of Pediatrics (AAP) has contradicted the US Centers for Disease Control and Prevention (CDC) over its recommended immunization schedule for children, specifically around COVID-19 shots. 21 August 2025
Pharmaceutical
Sweden’s Board for the Assessment of Pharmaceutical Information, NBL, has clarified the regulations for online advertising for pharmaceuticals with banners in a guiding statement . 18 August 2025
Pharmaceutical
The Swiss government has met with senior executives from Roche and Novartis to discuss the outlook for the pharmaceutical industry amid escalating US trade measures. 15 August 2025
Pharmaceutical
US President Donald Trump issued an executive order on August 13 2025 instructing the Department of Health and Human Services to assemble a six-month stockpile of active pharmaceutical ingredients (APIs) for around 26 critical drugs. 15 August 2025
Pharmaceutical
With the threat of US tariffs on pharmaceuticals looming in the coming weeks, Morningstar DBRS has taken a closer look at exposures among European Union (EU) countries and pharmaceutical companies. 13 August 2025
Pharmaceutical
US pharma major Eli Lilly is partnering with the UK’s Department for Science, Innovation and Technology to fund new approaches to obesity care across the National Health Service. 12 August 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze